01 July 2006
Activated Leukocyte Cell Adhesion Molecule (ALCAM) is associated with suppression of breast cancer cells invasion.
Agnieszka Jezierska, Wojciech P. Olszewski, Jerzy Pietruszkiewicz, Włodzimierz Olszewski, Wojciech Matysiak, Tomasz MotylMed Sci Monit 2006; 12(7): BR245-256 :: ID: 452197
Abstract
Background: Activated Leukocyte Cell Adhesion Molecule (ALCAM) is expressedin different kinds of normal and neoplastic tissues. Data on the tissue distribution of ALCAM suggestthat this protein is involved in tumor progression and metastasis. The lack of available data on ALCAMprotein expression in breast cancer prompted us to undertake a study on the involvement of this adhesionmolecule in tumor development. Material/Methods: The expressions of ALCAM and reference biomarkers wereexamined in 56 breast cancer specimens by laser scanning cytometry and confocal microscopy. The resultswere related to clinical and pathological parameters, i.e. histological grade, tumor diameter, lymphnode involvement, NPI, steroid receptor (estrogen, ER, and progesterone, PgR) expression, and HER2/neu over-expression. Results: High levels of ALCAM significantly correlated with small tumor diameter (p=0.009),low tumor grade (p=0.001), and the presence of progesterone (p=0.009) and estrogen (p=0.006) receptors.Declining ALCAM concentrations correlated with HER2/neu gene amplification, inasmuch as the obtainedp value, 0.065, was very close to the established statistical significance level of p=0.05. The ALCAM/MMP-2ratio was significantly higher in cancer cases characterized by small tumor size (p=0.04) and low tumorgrade (p=0.022). Conclusions: Analysis of ALCAM expression in relation to other molecular biomarkersrevealed that ALCAM expression and the ALCAM/MMP-2 ratio are more promising indicators of breast cancerprogression than MMP-2, E-cadherin, and alpha-catenin. Low ALCAM concentration correlated with an aggressivetumor phenotype, which supports the view that this adhesion molecule is a tumor suppressor marker withprognostic significance.
Keywords: Antigens, CD - physiology, Breast Neoplasms - pathology, Cell Adhesion Molecules, Neuronal - physiology, Estrogens - metabolism, Fetal Proteins - physiology, Fluorescent Antibody Technique, Genes, erbB-2, In Situ Hybridization, Fluorescence, Microscopy, Confocal, Receptors, Estrogen - metabolism, Receptors, Progesterone - metabolism
Editorial
01 October 2024 : Editorial
Editorial: Potentials and Pitfalls in Targeting Glucagon-Like Peptide-1 (GLP-1) in the Management of Increasing Levels of ObesityDOI: 10.12659/MSM.946675
Med Sci Monit 2024; 30:e946675
In Press
Clinical Research
Cold Pressor Test Induces Significant Changes in Internal Jugular Vein Flow Dynamics in Healthy Young AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.946055
Clinical Research
Serum Albumin-to-Creatinine Ratio Predicts One-Year Mortality in Elderly Patients with Non-ST-Elevation Acu...Med Sci Monit In Press; DOI: 10.12659/MSM.945516
Clinical Research
Uric Acid to Albumin Ratio as a Predictive Marker for Intracoronary Thrombus Severity in ST-Segment Elevati...Med Sci Monit In Press; DOI: 10.12659/MSM.945832
Database Analysis
Systematic Review of Arthroscopic Bankart Repair Outcomes for Anterior Shoulder InstabilityMed Sci Monit In Press; DOI: 10.12659/MSM.945942
Most Viewed Current Articles
17 Jan 2024 : Review article 6,057,955
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research 1,853,190
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 694,082
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
07 Jan 2022 : Meta-Analysis 258,356
Efficacy and Safety of Light Therapy as a Home Treatment for Motor and Non-Motor Symptoms of Parkinson Dise...DOI :10.12659/MSM.935074
Med Sci Monit 2022; 28:e935074